期刊文献+

不可切除晚期胰腺癌的综合治疗 被引量:2

Combined modality therapy of unresectable advanced pancreatic cancer
下载PDF
导出
摘要 胰腺癌(Pancreatic cancer,PC)恶性度高,肿瘤生长迅速,是癌症死亡常见病因之一,在欧美国家排名第4位,我国排名第9位。尽管目前在诊断方面有所进展,但80%以上患者确诊时已为不可切除的局部晚期或转移患者,所以在治疗上必须接受多学科综合治疗,如化疗、放疗、靶向治疗等。本文就目前各学科治疗进展进行综述,以期为不可切除晚期PC的临床综合治疗提供参考和依据。 Pancreatic cancer (PC) with high malignancy and rapid growth is the fourth leading cause of cancer related mortality in European and American Countries and the ninth in China.Despite improvements in diagnostic modalities,more than 80% of cases are still detected in nonresectable locally advanced or metastatic stages.A multidisciplinary approach to this disease is therefore recommended,such as chemotherapy,radiotherapy,targeted therapy.This paper will summarize current treatment progress to provide basis and reference for clinical comprehensive treatment of nonresectable advanced PC.
机构地区 长安医院肿瘤科
出处 《现代肿瘤医学》 CAS 2013年第11期2615-2619,共5页 Journal of Modern Oncology
关键词 胰腺癌 化疗 放疗 靶向治疗 综合治疗 pancreatic cancer chemotherapy radiotherapy targeted therapy combined modality therapy
  • 相关文献

参考文献1

二级参考文献1

共引文献6

同被引文献28

  • 1Jemal A,Siegel R,Ward E,et al.Cancer statistics,2007[J].CA Cancer J Clin,2007,57(1):43-66. 被引量:1
  • 2Burris HA 3rd,Moore MJ,Andersen J,et al.Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:A randomized trial[J].J Clin Oncol,1997,15(6):2403-2413. 被引量:1
  • 3Sung HY,Jung SE,Cho SH,et al.Long-term outcome of high-intensity focused ultrasound in advanced pancreatic cancer[J].Pancreas,2011,40(7):1080-1086. 被引量:1
  • 4Sofuni A,Moriyasu F,Sano T,et al.The current potential of high-intensity focused ultrasound for pancreatic carcinoma[J].J Hepatobiliary Pancreat Sci,2011,18(3):295-303. 被引量:1
  • 5Louvet C,Labianca R,Hammel P,et al.Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer:Results of a GERCOR and GISCAD phase III trial[J].J Clin Oncol,2005,23(15):3509-3516. 被引量:1
  • 6Baize N,Abu S halaa A,Berthier F,et al.Gemcitabine combined with oxaliplatin is safe and effective in patients with previously untreated advanced pancreatic adenocarcinoma[J].Gastroenterol Clin Biol,2005,29(10):1006-1009. 被引量:1
  • 7Demols A,Peeters M,Polus M,et al.Gemcitabine and oxaliplatin(GEMOX)in gemcitabine refractory advanced pancreatic adenocarcinoma:A phase II study[J].Br J Cancer,2006,94(4):481-485. 被引量:1
  • 8Fortune BE,Li X,Kosuri KV.Fixed-dose-rate gemcitabine in combination with oxaliplatin in patients with metastatic pancreaic cancer refractory to standard-dose-rate gemcitabine:A single-institute study[J].Oncology,2009,76(5):333-337. 被引量:1
  • 9Saif MW. Advancements in the management of pancreatic cancer [ J]. J Pancreas,2013,14(2) :112 -118. 被引量:1
  • 10Stomiolo AM, Enas NH, Brown CA, et al. An investigational new drug treatment program for patients with gemcitabine:resuhs for o- ver 3000 patients with panereatic carcinoma [ J]. Cancer, 1999,85 (6) :1261 - 1268. 被引量:1

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部